Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology

$4.8 million funding from Vsquared Ventures, Practica Capital and Metaplanet, bringing total funding to over $8 million New capital will support a worldwide commercial organisation, enabling

Related Keywords

Vilnius ,Vilniaus Apskritis ,Lithuania ,United States ,Lithuanian ,Lise Rechsteiner ,Juozas Nainys ,Julie Ferguson ,Atrandi Biosciences ,Donatas Keras ,Andy Watson ,Vsquared Ventures ,Practica Capital ,Business Wire ,Chief Executive Officer ,General Partner ,Droplet Genomics ,Board Chair ,Atrandi ,Iosciences ,Ecures ,Funding ,Advances ,Lobal ,Ommercialization ,Text ,Single ,Fell ,Analysis ,Technology ,